Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | +1.77% | +0.35% | -50.52% |
Financials (USD)
Sales 2024 * | 65.3M | Sales 2025 * | 6.25M | Capitalization | 18.79M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
0.79
x | P/E ratio 2025 * |
-0.5
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on MEI Pharma, Inc.
1 day | +1.77% | ||
1 week | +0.35% | ||
Current month | +0.35% | ||
1 month | -8.31% | ||
3 months | -18.93% | ||
6 months | -57.36% | ||
Current year | -50.52% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.87 | +1.77% | 6,476 |
24-06-06 | 2.82 | -2.08% | 35,478 |
24-06-05 | 2.88 | +2.86% | 48,895 |
24-06-04 | 2.8 | -3.78% | 112,428 |
24-06-03 | 2.91 | +1.75% | 30,184 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.52% | 18.79M | |
+51.85% | 59.28B | |
+41.42% | 40.94B | |
-5.25% | 40.17B | |
-5.16% | 28.69B | |
+12.79% | 26.63B | |
-20.18% | 18.89B | |
+30.88% | 12.46B | |
+0.61% | 12.42B | |
+25.06% | 12.26B |
- Stock Market
- Equities
- MEIP Stock